Isaac Kinde

16.9k total citations · 4 hit papers
32 papers, 5.9k citations indexed

About

Isaac Kinde is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Isaac Kinde has authored 32 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cancer Research, 12 papers in Pathology and Forensic Medicine and 11 papers in Oncology. Recurrent topics in Isaac Kinde's work include Cancer Genomics and Diagnostics (20 papers), Genetic factors in colorectal cancer (11 papers) and Cancer Cells and Metastasis (7 papers). Isaac Kinde is often cited by papers focused on Cancer Genomics and Diagnostics (20 papers), Genetic factors in colorectal cancer (11 papers) and Cancer Cells and Metastasis (7 papers). Isaac Kinde collaborates with scholars based in United States, Australia and Japan. Isaac Kinde's co-authors include Bert Vogelstein, Kenneth W. Kinzler, Jian Wu, Luis A. Díaz, Nikolaos G. Papadopoulos, Nickolas Papadopoulos, Benjamin Allen, Ivana Božić, Johannes G. Reiter and Jordan Berlin and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Isaac Kinde

32 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

2012 1.3k citations Luis A. Díaz, Richard T. Williams et al. Nature profile →
Detection and quantification of rare mutations with massively parallel sequencing

2011 857 citations Isaac Kinde, Jian Wu et al. Proceedings of the National Academy of Sciences profile →
Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing

2012 474 citations Isaac Kinde, Nickolas Papadopoulos et al. profile →
Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer

2015 464 citations Jeanne Tie, Isaac Kinde et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Isaac Kinde United States	24	3.6k	2.2k	2.2k	1.7k	1.4k	32	5.9k
Elena F. Brachtel United States	35	2.1k 0.6×	2.8k 1.3×	1.6k 0.7×	743 0.4×	687 0.5×	89	5.7k
Carel J.M. van Noesel Netherlands	43	788 0.2×	2.1k 1.0×	1.6k 0.7×	672 0.4×	2.0k 1.5×	118	6.0k
Wolfram Brugger Germany	51	785 0.2×	4.7k 2.1×	2.9k 1.4×	2.1k 1.2×	2.2k 1.6×	191	10.6k
Katia Schlienger United States	25	1.0k 0.3×	4.4k 2.0×	1.4k 0.6×	649 0.4×	310 0.2×	52	7.3k
Jacqueline Lehmann‐Che France	31	1.3k 0.4×	1.0k 0.5×	1.5k 0.7×	555 0.3×	233 0.2×	89	3.4k
Helen Won United States	28	1.2k 0.3×	1.8k 0.8×	1.9k 0.9×	1.4k 0.8×	454 0.3×	61	4.1k
Alan J. Korman United States	55	690 0.2×	10.0k 4.6×	2.8k 1.3×	1.5k 0.9×	540 0.4×	113	15.6k
Michelle S. Hirsch United States	45	1.3k 0.4×	1.7k 0.8×	2.5k 1.1×	2.3k 1.4×	459 0.3×	194	7.5k
Ralf Küppers Germany	69	1.7k 0.5×	7.1k 3.3×	4.0k 1.8×	869 0.5×	10.4k 7.7×	264	18.9k
Paul G. Murray United Kingdom	39	1.1k 0.3×	2.9k 1.3×	2.0k 0.9×	370 0.2×	1.5k 1.1×	92	5.4k

Countries citing papers authored by Isaac Kinde

Since Specialization

Citations

This map shows the geographic impact of Isaac Kinde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isaac Kinde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isaac Kinde more than expected).

Fields of papers citing papers by Isaac Kinde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isaac Kinde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isaac Kinde. The network helps show where Isaac Kinde may publish in the future.

Co-authorship network of co-authors of Isaac Kinde

This figure shows the co-authorship network connecting the top 25 collaborators of Isaac Kinde. A scholar is included among the top collaborators of Isaac Kinde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isaac Kinde. Isaac Kinde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Papadopoulos, Nickolas, Anne Marie Lennon, Darl D. Flake, et al.. (2023). 202P Participant perceptions and mammography adherence from DETECT-A: The first prospective interventional trial of a multi-cancer early detection (MCED) blood test. Annals of Oncology. 34. S262–S263. 1 indexed citations

Wang, Yuxuan, Lu Li, Joshua D. Cohen, et al.. (2019). Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal Cancer. JAMA Oncology. 5(8). 1118–1118. 149 indexed citations

Tie, Jeanne, Joshua D. Cohen, Yuxuan Wang, et al.. (2017). The potential of circulating tumor DNA (ctDNA) to guide adjuvant chemotherapy decision making in locally advanced rectal cancer (LARC).. Journal of Clinical Oncology. 35(15_suppl). 3521–3521. 11 indexed citations

Taheri, Diana, Simeon Springer, Morgan L. Cowan, et al.. (2016). High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 469(4). 427–434. 32 indexed citations

Cowan, Morgan L., Simeon Springer, Diana Taheri, et al.. (2016). Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder. Human Pathology. 53. 8–13. 29 indexed citations

Cowan, Morgan L., Simeon Springer, Diana Taheri, et al.. (2016). High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder. Modern Pathology. 29(5). 511–515. 31 indexed citations

Tie, Jeanne, Isaac Kinde, Y. Wang, et al.. (2015). Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer. Annals of Oncology. 26(8). 1715–1722. 464 indexed citations breakdown →

Wang, Yuxuan, Reinhard Horvat, Els Van Nieuwenhuysen, et al.. (2015). Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept Study. Journal of Clinical Oncology. 33(36). 4293–4300. 78 indexed citations

Tie, Jeanne, Isaac Kinde, Yuxuan Wang, et al.. (2014). Circulating tumor DNA (ctDNA) as a marker of recurrence risk in stage II colon cancer (CC).. Journal of Clinical Oncology. 32(15_suppl). 11015–11015. 15 indexed citations

10.

Erickson, Britt, Isaac Kinde, Zachary C. Dobbin, et al.. (2014). Detection of Somatic TP53 Mutations in Tampons of Patients With High-Grade Serous Ovarian Cancer. Obstetrics and Gynecology. 124(5). 881–885. 33 indexed citations

11.

Joseph, Christine, Erika Darrah, Ami A. Shah, et al.. (2013). Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer. Science. 343(6167). 152–157. 300 indexed citations

12.

Kinde, Isaac, Enrico Munari, Sheila F. Faraj, et al.. (2013). TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine. Cancer Research. 73(24). 7162–7167. 200 indexed citations

13.

Tie, Jeanne, Isaac Kinde, Hui‐Li Wong, et al.. (2013). Massively parallel sequencing (MPS) of circulating DNA in patients with metastatic colorectal cancer (mCRC): Prognostic significance and early changes during chemotherapy (CT).. Journal of Clinical Oncology. 31(15_suppl). 11015–11015. 1 indexed citations

14.

Joseph, Christine, Yuchen Jiao, Laura D. Wood, et al.. (2013). Exomic analysis of myxoid liposarcomas, synovial sarcomas, and osteosarcomas. Genes Chromosomes and Cancer. 53(1). 15–24. 77 indexed citations

15.

Díaz, Luis A., Richard T. Williams, Jian Wu, et al.. (2012). The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature. 486(7404). 537–540. 1290 indexed citations breakdown →

16.

Kinde, Isaac, Nickolas Papadopoulos, Kenneth W. Kinzler, & Bert Vogelstein. (2012). FAST-SeqS: A Simple and Efficient Method for the Detection of Aneuploidy by Massively Parallel Sequencing. PLoS ONE. 7(7). e41162–e41162. 49 indexed citations

17.

Kinde, Isaac, Jian Wu, Nikolaos G. Papadopoulos, Kenneth W. Kinzler, & Bert Vogelstein. (2011). Detection and quantification of rare mutations with massively parallel sequencing. Proceedings of the National Academy of Sciences. 108(23). 9530–9535. 857 indexed citations breakdown →

18.

Kelly, Brian N., Isaac Kinde, Chun Tang, et al.. (2007). Structure of the Antiviral Assembly Inhibitor CAP-1 Complex with the HIV-1 CA Protein. Journal of Molecular Biology. 373(2). 355–366. 133 indexed citations

19.

Tang, Chun, Erin Loeliger, Paz J. Luncsford, et al.. (2003). Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proceedings of the National Academy of Sciences. 101(2). 517–522. 258 indexed citations

20.

Tang, Chun, Erin Loeliger, Isaac Kinde, et al.. (2003). Antiviral Inhibition of the HIV-1 Capsid Protein. Journal of Molecular Biology. 327(5). 1013–1020. 188 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact